Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Anticancer Research|June 10, 2019
Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted TherapiesZiad El Ali, Sylvie Rottey, Philippe Barthelemy, et al.European Journal of Cancer (Oxford, England : 1990)|December 31, 2019
Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinomaFrede Donskov, Robert J Motzer, Eric Voog, et al.BMC Cancer|December 3, 2021
Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)Nieves Martinez Chanza, Louisa Soukane, Philippe Barthelemy, et al.The Lancet. Oncology|June 8, 2013
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trialIan F Tannock, Karim Fizazi, Sergey Ivanov, et al.Acta Oncologica (Stockholm, Sweden)|August 22, 2020
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panelGiacomo Bregni, Tiberio Sticca, Silvia Camera, et al.Urologic Oncology|February 7, 2016
Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use programCharles Van Praet, Sylvie Rottey, Fransien Van Hende, et al.Clinical Genitourinary Cancer|March 5, 2017
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?Charles Van Praet, Sylvie Rottey, Fransien Van Hende, et al.The Oncologist|August 18, 2022
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell CarcinomasJonathan Thouvenin, Omar Alhalabi, Maria Carlo, et al.Pageof 5